Characterization, GFP Gene Nucleofection, and Allotransplantation in Injured Tendons of Ovine Amniotic Fluid-Derived Stem Cells

Amniotic fluid has drawn increasing attention in the recent past as a cost-effective and accessible source of fetal stem cells. Amniotic fluid-derived mesenchymal stem cells (AFMSCs) that display high proliferation rate, large spectrum of differentiation potential, and immunosuppressive features are considered optimal candidates for allogeneic repair of mesenchymal damaged tissues. In this study, ovine AFMSCs (oAFMSCs) isolated from 3-month-old sheep fetuses were characterized for their proliferation rate, specific surface antigen and pluripotency marker expression, genomic stability, and mesenchymal lineage differentiation during their in vitro expansion (12 passages) and after nucleofection. The high proliferation rate of oAFMSCs gradually decreased during the first six subculture passages while the expression of surface molecules (CD29, CD58, CD166) and of pluripotency-associated markers (OCT4, TERT, NANOG, SOX2), the in vitro osteogenic differentiation potential, and a normal karyotype were maintained. Afterwards, oAFMSCs were nucleofected with a selectable plasmid coding for green fluorescent protein (GFP) using two different programs, U23 and C17, previously optimized for human mesenchymal stem cells. Transfection efficiencies were ~63% and ~37%, while cell recoveries were ~10% and ~22%, respectively. Nucleofected oAFMSCs expressing the GFP transgene conserved their pluripotency marker profile and retained a normal karyotype and the osteogenic differentiation ability. Seven single clones with a GFP expression ranging from 80% to 97% were then isolated and expanded over 1 month, thus providing stably transfected cells with long-term therapeutic potential. The in vivo behavior of GFP-labeled oAFMSCs was tested on a previously validated preclinical model of experimentally induced Achille's tendon defect. The allotransplanted oAFMSCs were able to survive within the host tissue for 1 month enhancing the early phase of tendon healing as indicated by morphological and biomechanical results. Altogether these data suggest that genetically modified oAFMSCs might represent a valuable tool for in vivo preclinical studies in a highly valid translational model.

[1]  G. Novelli,et al.  Transfer and expression of foreign genes in mammalian cells. , 2000, BioTechniques.

[2]  Zhi-Xing An,et al.  Neurogenic differentiation of EGFP gene transfected amniotic fluid-derived stem cells from pigs at intermediate and late gestational ages. , 2009, Reproduction in domestic animals = Zuchthygiene.

[3]  Yue-mao Zheng,et al.  Adipogenic differentiation and EGFP gene transfection of amniotic fluid‐derived stem cells from goat fetus at terminal gestational age , 2011, Cell biology international.

[4]  Shaun A. Steigman,et al.  A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. , 2007, Tissue engineering.

[5]  Toshio Miki,et al.  Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells , 2008, Stem cells.

[6]  Qing Luo,et al.  Indirect co-culture with tenocytes promotes proliferation and mRNA expression of tendon/ligament related genes in rat bone marrow mesenchymal stem cells , 2009, Cytotechnology.

[7]  D. Schmidt,et al.  Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? , 2009, Regenerative medicine.

[8]  K. Satomura,et al.  Repair of craniotomy defects using bone marrow stromal cells. , 1998, Transplantation.

[9]  B. Corradetti,et al.  Fetal adnexa derived stem cells from domestic animal: progress and perspectives. , 2011, Theriogenology.

[10]  D. Brunetti,et al.  Transgene expression of green fluorescent protein and germ line transmission in cloned pigs derived from in vitro transfected adult fibroblasts. , 2008, Cloning and stem cells.

[11]  Y. Tabata,et al.  Non-viral gene transfection technologies for genetic engineering of stem cells. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  S. Sedrakyan,et al.  Characterization of human amniotic fluid stem cells and their pluripotential capability. , 2008, Methods in cell biology.

[13]  A. Angelini,et al.  Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[15]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[16]  D. Russell,et al.  Chromosomal position effects on AAV-mediated gene targeting , 2010, Nucleic Acids Research.

[17]  A. Mauro,et al.  Experimental study on allografts of amniotic epithelial cells in calcaneal tendon lesions of sheep , 2010, Veterinary Research Communications.

[18]  N. Anagnou,et al.  Novel sources of fetal stem cells: where do they fit on the developmental continuum? , 2009, Regenerative medicine.

[19]  Zhe Wang,et al.  Cytogenetic analysis of human bone marrow‐derived mesenchymal stem cells passaged in vitro , 2007, Cell biology international.

[20]  S. Balasubramanian,et al.  Porcine mesenchymal stem cells--current technological status and future perspective. , 2009, Frontiers in bioscience.

[21]  Stefan Milz,et al.  Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regeneration. , 2010, Tissue engineering. Part A.

[22]  K. Kang,et al.  Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. , 2011, Cytotherapy.

[23]  H. Kim,et al.  Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cells , 2007, Cell proliferation.

[24]  I. Singh,et al.  Expression of pluripotency genes in buffalo (Bubalus bubalis) amniotic fluid cells. , 2011, Reproduction in domestic animals = Zuchthygiene.

[25]  N. Aghdami,et al.  Mesenchymal stem cells from murine amniotic fluid as a model for preclinical investigation. , 2011, Archives of Iranian medicine.

[26]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[27]  A. Porter,et al.  A chromosomal position effect on gene targeting in human cells. , 2002, Nucleic acids research.

[28]  M. Sikorska,et al.  Probing Stemness and Neural Commitment in Human Amniotic Fluid Cells , 2010, Stem Cell Reviews and Reports.

[29]  R. Palmiter,et al.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Warden.  Development and use of animal models to advance tendinopathy research. , 2009, Frontiers in bioscience.

[31]  Susana Castro-Obregon,et al.  New non-viral method for gene transfer into primary cells. , 2004, Methods.

[32]  A. Mauro,et al.  Sheep Calcaneal Tendon Repair Subsequent to Amniotic-Derived Stem Cell Allotransplantation , 2012 .

[33]  V. Fuster,et al.  Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. , 2009, Cellular reprogramming.

[34]  Y-M Zheng,et al.  Characteristics and EGFP expression of goat mammary gland epithelial cells. , 2010, Reproduction in domestic animals = Zuchthygiene.

[35]  D. Hutmacher,et al.  Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore. , 2005, Annals of the Academy of Medicine, Singapore.

[36]  E. Horwitz,et al.  How do mesenchymal stromal cells exert their therapeutic benefit? , 2008, Cytotherapy.

[37]  C. Recordati,et al.  Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells , 2011, Veterinary Research Communications.

[38]  L. Stuppia,et al.  Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol , 2009, BMC biotechnology.

[39]  S. Gronthos,et al.  Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells , 2009, Journal of cellular physiology.

[40]  S. Gronthos,et al.  The efficacy of allogeneic mesenchymal precursor cells for the repair of an ovine tibial segmental defect , 2011, Veterinary and Comparative Orthopaedics and Traumatology.

[41]  A. Mauro,et al.  Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells , 2010, Veterinary Research Communications.

[42]  M. Miloso,et al.  Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells , 2009, Chromosome Research.

[43]  Kazuhiro Sudo,et al.  Efficient Transfection of Embryonic and Adult Stem Cells , 2004, Stem cells.

[44]  A. David,et al.  Autologous Transplantation of Amniotic Fluid-Derived Mesenchymal Stem Cells into Sheep Fetuses , 2011, Cell transplantation.

[45]  A. Vlahou,et al.  In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells , 2011, Journal of cellular and molecular medicine.

[46]  J. Cook,et al.  Reporter genes: application to the study of mammalian gene transcription. , 1990, Analytical biochemistry.

[47]  Guilai Shi,et al.  Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. , 2009, Human molecular genetics.

[48]  D. Bianchi,et al.  Cell-free fetal nucleic acids in amniotic fluid. , 2011, Human reproduction update.

[49]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[50]  M. Baccarani,et al.  Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.

[51]  P. Guillot,et al.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues , 2010, Journal of The Royal Society Interface.

[52]  S. Hua,et al.  Development of cloned embryos from porcine neural stem cells and amniotic fluid-derived stem cells transfected with enhanced green fluorescence protein gene. , 2009, Reproduction.

[53]  H. Ouyang,et al.  Stem cells for tendon tissue engineering and regeneration , 2010, Expert opinion on biological therapy.

[54]  Paolo Giannoni,et al.  A tissue engineering approach to bone repair in large animal models and in clinical practice. , 2007, Biomaterials.

[55]  D. Zurakowski,et al.  Chest wall repair with engineered fetal bone grafts: an efficacy analysis in an autologous leporine model. , 2010, Journal of pediatric surgery.

[56]  D. Laván,et al.  Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. , 2004, Journal of pediatric surgery.

[57]  D. Freedman,et al.  Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. , 2006, Journal of pediatric surgery.

[58]  David Zurakowski,et al.  Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. , 2011, Journal of pediatric surgery.

[59]  S. H. Park,et al.  Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells , 2010, BMC biotechnology.

[60]  Munish C. Gupta,et al.  Efficacy of Mesenchymal Stem Cell Enriched Grafts in an Ovine Posterolateral Lumbar Spine Model , 2007, Spine.

[61]  Ren-Ke Li,et al.  A Transformed Cell Population Derived from Cultured Mesenchymal Stem Cells has no Functional Effect after Transplantation into the Injured Heart , 2009, Cell transplantation.

[62]  W. Plitz,et al.  Achilles tendon rupture: experimental results on spontaneous repair in a sheep-model , 2000, Knee Surgery, Sports Traumatology, Arthroscopy.

[63]  D. de Semir,et al.  Comparative transfection of DNA into primary and transformed mammalian cells from different lineages , 2010, BMC biotechnology.

[64]  A. Vlahou,et al.  Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. , 2007, Stem cells and development.

[65]  A. Atala,et al.  Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. , 2007, The Journal of urology.

[66]  P. Leoni,et al.  Human Mesenchymal Stem Cells from Chorionic Villi and Amniotic Fluid are not Susceptible to Transformation after Extensive in Vitro Expansion , 2011, Cell transplantation.

[67]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[68]  T. Liehr,et al.  Chromosome variability of human multipotent mesenchymal stromal cells , 2007, Bulletin of Experimental Biology and Medicine.

[69]  C. Heeschen,et al.  Genetically engineered stem cells for therapeutic gene delivery. , 2007, Current gene therapy.

[70]  A. Atala,et al.  High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. , 2008, Stem cells and development.

[71]  G. Rossi,et al.  Histology and immunohistochemistry study of ovine tendon grafted with cBMSCs and BMMNCs after collagenase-induced tendinitis , 2008, Veterinary and Comparative Orthopaedics and Traumatology.

[72]  Giacomo Rossi,et al.  Histological and Immunohistochemical Evaluation of Autologous Cultured Bone Marrow Mesenchymal Stem Cells and Bone Marrow Mononucleated Cells in Collagenase-Induced Tendinitis of Equine Superficial Digital Flexor Tendon , 2010, Veterinary medicine international.

[73]  R. Samulski,et al.  Role of viral vectors and virion shells in cellular gene expression. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[75]  D. Bianchi,et al.  Large amounts of cell-free fetal DNA are present in amniotic fluid. , 2001, Clinical chemistry.